Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of patients and offering new hope for those with the life-threatening condition.

A new study compared the effectiveness of weight-loss drugs tirzepatide and semaglutide, finding tirzepatide leads to greater weight loss and waist reduction. Doctors shared insights.

How Long Can You Take Semaglutide for Weight Loss? There’s no cut-off for when you need to stop taking semaglutide — you may be able to take it long-term.

Semaglutide is the active ingredient in the weight loss medication Wegovy and the diabetes drugs Ozempic and Rybelsus, which are sometimes taken off-label for weight loss.

Compounded semaglutide, ubiquitous online, has certainly stepped into the void to make this therapy more accessible to the general public. But in the process, ...

Compounded semaglutide, the active ingredient in Ozempic and Wegovy, is a version of the drug that has been mixed with other medications or ingredients. More From Newsweek Vault: ...

Tirzepatide and semaglutide are type 2 diabetes drugs that are often used for weight loss. While tirzepatide may potentially be more effective, it's too early to know that based on current research.

The diabetes and weight loss drug semaglutide may also reverse signs of liver disease. That’s the headline result of a new clinical trial that tested the popular medication in patients with MASH ...

See all the celebrities who've talked about semaglutide and tirzepitide GLP-1 drugs including Ozempic, Mounjaro, Zepbound and Wegovy (including whether or not they've used the drug for weight loss ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name Ozempic — may help reduce not only alcohol cravings, but the amount of ...

Semaglutide is revolutionizing kidney disease treatment for type 2 diabetes patients. Learn how it works and its potential impact on CKD.

Being prescribed semaglutide for diabetes or weight management is associated with an increased risk, up to seven times, of developing a relatively rare form of untreatable blindness, sometimes ...